Brief: NextCell Pharma:ProTrans Cell Therapy To Be Granted Patent Protection Beyond Europe
25/08/2022 12:17
Aug 25 (Reuters) - NextCell Pharma AB NXTCL.ST :
* PROTRANS CELL THERAPY TO BE GRANTED PATENT PROTECTION
BEYOND
EUROPE
* NEXTCELL PHARMA AB - JAPAN PATENT OFFICE (JPO) HAS ISSUED
A
NOTICE OF ALLOWANCE RELATING TO PATENT ENTITLED "ALLOGENEIC
COMPOSITION"
Source text for Eikon: ID:nWkr7pJF18
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln